John D. Morrey Copyright (c) 2012 All rights reserved. http://works.bepress.com/john_morrey Recent documents in John D. Morrey en-us Sat, 24 Nov 2012 21:39:21 PST 3600 West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters http://works.bepress.com/john_morrey/142 http://works.bepress.com/john_morrey/142 Fri, 14 Sep 2012 09:17:48 PDT H Wang et al. Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice http://works.bepress.com/john_morrey/141 http://works.bepress.com/john_morrey/141 Fri, 14 Sep 2012 09:17:47 PDT John D. Morrey et al. Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T) http://works.bepress.com/john_morrey/140 http://works.bepress.com/john_morrey/140 Fri, 14 Sep 2012 09:17:46 PDT R W. Sidwell et al. HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice http://works.bepress.com/john_morrey/139 http://works.bepress.com/john_morrey/139 Fri, 14 Sep 2012 09:17:45 PDT John D. Morrey et al. Early detection of bovine leukemia virus in experimentally infected cattle by polymerase chian reaction http://works.bepress.com/john_morrey/138 http://works.bepress.com/john_morrey/138 Fri, 14 Sep 2012 09:17:44 PDT E J. Kelly et al. In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice http://works.bepress.com/john_morrey/137 http://works.bepress.com/john_morrey/137 Fri, 14 Sep 2012 09:17:42 PDT John D. Morrey et al. Use of pre-s protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection http://works.bepress.com/john_morrey/136 http://works.bepress.com/john_morrey/136 Fri, 14 Sep 2012 09:17:41 PDT J S. Yum et al. Effect of imexon treatment on Friend virus complex infection in genetically defined mice as a model for HIV infection http://works.bepress.com/john_morrey/135 http://works.bepress.com/john_morrey/135 Fri, 14 Sep 2012 09:17:40 PDT John D. Morrey et al. Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus http://works.bepress.com/john_morrey/134 http://works.bepress.com/john_morrey/134 Fri, 14 Sep 2012 09:17:39 PDT J G. Julander et al. Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP) http://works.bepress.com/john_morrey/133 http://works.bepress.com/john_morrey/133 Fri, 14 Sep 2012 09:17:38 PDT D R. Gustafson et al. Murine retroviral disease-enhancing effects of pyrimidinone immunomodulator http://works.bepress.com/john_morrey/132 http://works.bepress.com/john_morrey/132 Fri, 14 Sep 2012 09:17:37 PDT R P. Warren et al. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus http://works.bepress.com/john_morrey/131 http://works.bepress.com/john_morrey/131 Fri, 14 Sep 2012 09:17:36 PDT J G. Julander et al. Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1 http://works.bepress.com/john_morrey/130 http://works.bepress.com/john_morrey/130 Fri, 14 Sep 2012 09:17:35 PDT C A. Smeraski et al. Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response http://works.bepress.com/john_morrey/129 http://works.bepress.com/john_morrey/129 Fri, 14 Sep 2012 09:17:33 PDT M Mendenhall et al. Transgenic hepatitis B virus mouse model in the study of chemotherapy http://works.bepress.com/john_morrey/128 http://works.bepress.com/john_morrey/128 Fri, 14 Sep 2012 09:17:32 PDT John D. Morrey Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropinclass lytic peptide in transgenic mice and subsequent resistance to Brucella abortus http://works.bepress.com/john_morrey/127 http://works.bepress.com/john_morrey/127 Fri, 14 Sep 2012 09:17:31 PDT W A. Reed et al. Transgenic mice as a chemotherapeutic model for hepatitis B virus infection http://works.bepress.com/john_morrey/126 http://works.bepress.com/john_morrey/126 Fri, 14 Sep 2012 09:17:30 PDT John D. Morrey et al. Error-prone replication of West Nile virus caused by ribavirin http://works.bepress.com/john_morrey/125 http://works.bepress.com/john_morrey/125 Fri, 14 Sep 2012 09:17:29 PDT C W. Day et al. Transgenic mice as a chemotherapeutic model for HBV infection http://works.bepress.com/john_morrey/124 http://works.bepress.com/john_morrey/124 Fri, 14 Sep 2012 09:17:28 PDT John D. Morrey et al. Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus http://works.bepress.com/john_morrey/123 http://works.bepress.com/john_morrey/123 Fri, 14 Sep 2012 09:17:27 PDT G Y. Song et al.